Rapid improvements in health-related quality of life and itch with ixekizumab treatment in randomized phase 3 trials: results from UNCOVER-2 and UNCOVER-3-Reference-Cited by-同舟云学术

Rapid improvements in health-related quality of life and itch with ixekizumab treatment in randomized phase 3 trials: results from UNCOVER-2 and UNCOVER-3

Published:2017-06-28 Issue:9 Volume:31 Page:1483-1490
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:J Eur Acad Dermatol Venereol

Author:

Leonardi C.L.¹,Blauvelt A.²,Sofen H.L.³,Gooderham M.⁴,Augustin M.⁵,Burge R.⁶⁷,Zhu B.⁶,Reich K.⁸

Affiliation:

1. Central Dermatology; St Louis MO USA

2. Oregon Medical Research Center; Portland OR USA

3. Department of Medicine (Dermatology); David Geffen School of Medicine; Los Angeles CA USA

4. SKiN Centre for Dermatology and Queen's University; Peterborough ON Canada

5. Institute for Health Services Research in Dermatology and Nursing; University Medical Center Hamburg; Hamburg Germany

6. Eli Lilly and Company; Indianapolis IN USA

7. University of Cincinnati; Cincinnati OH USA

8. Dermatologikum Hamburg and SCIderm Research Institute; Hamburg Germany

Funder

Eli Lilly and Company

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jdv.14211/fullpdf

Reference34 articles.

1. The impact of psoriasis on quality of life;Arruda;Br J Dermatol,2001

2. Trivial or terrible? The psychosocial impact of psoriasis;Fried;Int J Dermatol,1995

3. The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey;Krueger;Arch Dermatol,2001

4. Psoriasis today: experiences of healthcare and impact on quality of life in a major UK cohort;Nash;Prim Health Care Res Dev,2015

5. Patients' perspective of pruritus in chronic plaque psoriasis: a questionnaire-based study;Amatya;J Eur Acad Dermatol Venereol,2008

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ixekizumab for the treatment of moderate-to-severe plaque psoriasis: the first septennium;Immunotherapy;2023-10

2. Ixekizumab is effective in the long-term management in moderate-to-severe plaque psoriasis: results from an Italian retrospective cohort study (the LOTIXE study);Journal of Dermatological Treatment;2023-08-17

3. A systematic review of 454 randomized controlled trials using the Dermatology Life Quality Index: experience in 69 diseases and 43 countries;British Journal of Dermatology;2023-03-27

4. Effectiveness of brodalumab in improving itching and skin pain in Japanese patients with psoriasis: The ProLOGUE study;The Journal of Dermatology;2022-12-20

5. Value of PASI90 Versus Merit-Based Incentive Payment System Efficacy Measures;Journal of Psoriasis and Psoriatic Arthritis;2022-04-19